Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Glia. 2012 Jul;60(7):1130-44. doi: 10.1002/glia.22340. Epub 2012 Apr 17.
We previously reported that addition of extracellular matrix (ECM) extracts to rat Schwann cell-dorsal root ganglion neuron (DRGN) co-cultures activated mitogen-activated protein kinase (MAPK) p38, whereas inhibition blocked myelination. Here, we used p38 pharmacological inhibitors and gene silencing to assess their effects on downstream kinases and key transcription factors. We show that p38α regulates expression of the master transcription factor, Krox-20, required for the onset of myelination in Schwann cell-DRGNs, as assessed by immunocytochemistry and qRT-PCR. p38 activity is also required for the expression of the cell cycle inhibitor p27(kip1) , associated with Schwann cell differentiation. Three potential effectors of p38 were explored: MAPK-activated protein kinase-2 (MK2), mitogen and stress-activated protein kinase-1 (MSK-1), and the transcription factor cAMP response element-binding protein (CREB). Inhibition of MK2 with CMPD1 or gene knockdown with siRNAs reduced numbers of Krox-20-positive Schwann cells and expression of myelin proteins MBP and MAG. ECM activated CREB and increased Krox-20 expression, whereas CREB1 gene silencing reduced Krox-20. Furthermore, two nonselective inhibitors of MSK-1 (H89 and R0-318820) decreased ECM-induced CREB phosphorylation and, similar to anti-MSK-1 siRNAs, reduced Krox-20-positive cells. In addition, p38 modulated the expression of two transcription factors involved in the regulation of Krox-20 [suppressed cAMP-inducible protein (SCIP) and Sox10], but not Sox2, an antagonist of Krox-20. Collectively, our results show that p38 primarily directs Schwann cell differentiation and peripheral myelination by regulating Krox-20 expression through its downstream effectors, MK2 and MSK-1/CREB, and transcription factors SCIP and Sox10.
我们之前曾报道过,在大鼠许旺细胞-背根神经节神经元(DRGN)共培养物中添加细胞外基质(ECM)提取物可激活丝裂原活化蛋白激酶(MAPK)p38,而抑制 p38 则可阻止髓鞘形成。在此,我们使用 p38 药理学抑制剂和基因沉默来评估它们对下游激酶和关键转录因子的影响。我们发现,p38α 调节许旺细胞-DRGN 中髓鞘形成起始所必需的主转录因子,Krox-20 的表达,这通过免疫细胞化学和 qRT-PCR 来评估。p38 活性对于细胞周期抑制剂 p27(kip1)的表达也是必需的,p27(kip1)与许旺细胞分化有关。探索了 p38 的三个潜在效应物:MAPK 激活的蛋白激酶-2(MK2)、有丝分裂原和应激激活蛋白激酶-1(MSK-1)和转录因子 cAMP 反应元件结合蛋白(CREB)。用 CMPD1 抑制 MK2 或用 siRNA 基因敲低可减少 Krox-20 阳性许旺细胞的数量和髓鞘蛋白 MBP 和 MAG 的表达。ECM 激活 CREB 并增加 Krox-20 的表达,而 CREB1 基因沉默则降低 Krox-20 的表达。此外,两种非选择性 MSK-1 抑制剂(H89 和 R0-318820)降低 ECM 诱导的 CREB 磷酸化,并且与抗 MSK-1 siRNA 相似,减少了 Krox-20 阳性细胞。此外,p38 调节了两个参与 Krox-20 调控的转录因子的表达[抑制性 cAMP 诱导蛋白(SCIP)和 Sox10],但不调节 Krox-20 的拮抗剂 Sox2。总的来说,我们的结果表明,p38 主要通过其下游效应物 MK2 和 MSK-1/CREB 以及转录因子 SCIP 和 Sox10 调节 Krox-20 的表达,从而指导许旺细胞的分化和周围髓鞘的形成。